Related Experiment Video

Updated: Mar 6, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

20.2K

Metformin - its potential anti-cancer and anti-aging effects

Monika Podhorecka1, Blanca Ibanez1, Anna Dmoszyńska2

  • 1Department of Hematooncology and Bone Marrow Transplantation Medical University of Lublin.

Postepy Higieny I Medycyny Doswiadczalnej (Online)
|March 5, 2017
PubMed

Insights

Metformin, a diabetes drug, shows promise beyond blood sugar control. This review explores its potential anti-cancer and anti-aging effects, possibly through novel pathways beyond AMPK activation.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Gerontology

Background:

  • Metformin is a widely used drug for type 2 diabetes.
  • Its primary mechanism involves stimulating AMP-activated protein kinase (AMPK).
  • Emerging research suggests metformin has effects beyond metabolic regulation.

Purpose of the Study:

  • To review the potential anti-cancer properties of metformin.
  • To explore the anti-aging effects of metformin.
  • To discuss the underlying molecular mechanisms for these effects.

Main Methods:

  • Literature review of preclinical and clinical studies.
  • Analysis of research on metformin's molecular targets.
  • Synthesis of evidence regarding non-glycemic effects.

Main Results:

  • Metformin exhibits anti-cancer activity through various pathways, including AMPK-dependent and independent mechanisms.
  • Evidence suggests metformin may influence aging processes, potentially by modulating cellular stress responses.
  • Novel pathways beyond AMPK activation are implicated in metformin's diverse biological effects.

Conclusions:

  • Metformin possesses potential therapeutic applications in oncology and gerontology.
  • Further research into these novel mechanisms could identify new therapeutic targets.
  • Metformin's multifaceted actions warrant continued investigation for metabolic syndrome and beyond.

More Related Videos

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

13.9K
Techniques to Induce and Quantify Cellular Senescence06:51

Techniques to Induce and Quantify Cellular Senescence

Published on: May 1, 2017

35.3K

Related Concept Videos

Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
762
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
283
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
562
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K